These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 17193266)

  • 1. Synthesis of aminooxy-functionalized lanthanide(III) chelates for carbonyl-group conjugation.
    Hovinen J
    Chem Biodivers; 2006 Mar; 3(3):296-303. PubMed ID: 17193266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioconjugation with stable luminescent lanthanide(III) chelates comprising pyridine subunits.
    Hovinen J; Guy PM
    Bioconjug Chem; 2009 Mar; 20(3):404-21. PubMed ID: 19072705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Convenient synthesis of maleimido-derivatized lanthanide(III) chelates and their use in mercapto group conjugation.
    Hovinen J
    Bioconjug Chem; 2007; 18(2):597-600. PubMed ID: 17341106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thiol-reactive luminescent lanthanide chelates: part 2.
    Ge P; Selvin PR
    Bioconjug Chem; 2003; 14(5):870-6. PubMed ID: 13129389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and optical properties of macrocyclic lanthanide(III) chelates as new reagents for luminescent biolabeling.
    Deslandes S; Galaup C; Poole R; Mestre-Voegtlé B; Soldevila S; Leygue N; Bazin H; Lamarque L; Picard C
    Org Biomol Chem; 2012 Nov; 10(42):8509-23. PubMed ID: 23011114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Labeling of proteins and oligopeptides with luminescent lanthanide(III) chelates.
    Jaakkola L; Peuralahti J; Hakala H; Mukkala VM; Hurskainen P; Hovinen J
    J Pept Sci; 2006 Mar; 12(3):199-205. PubMed ID: 16059969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorescent and lanthanide labeling for ligand screens, assays, and imaging.
    Josan JS; De Silva CR; Yoo B; Lynch RM; Pagel MD; Vagner J; Hruby VJ
    Methods Mol Biol; 2011; 716():89-126. PubMed ID: 21318902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of novel macrocyclic lanthanide chelates derived from bis-pyrazolylpyridine.
    Brunet E; Juanes O; Sedano R; Rodríguez-Ubis JC
    Org Lett; 2002 Jan; 4(2):213-6. PubMed ID: 11796053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of nonluminescent lanthanide(III) chelates tethered to an aminooxy group and their applicability to biomolecule derivatization.
    Peuralahti J; Puukka K; Hakala H; Mukkala VM; Mulari O; Hurskainen P; Hovinen J
    Bioconjug Chem; 2002; 13(4):876-80. PubMed ID: 12121144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A robust and convergent synthesis of dipeptide-DOTAM conjugates as chelators for lanthanide ions: new PARACEST MRI agents.
    Wojciechowski F; Suchy M; Li AX; Azab HA; Bartha R; Hudson RH
    Bioconjug Chem; 2007; 18(5):1625-36. PubMed ID: 17711349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formation kinetics and stability studies on the lanthanide complexes of 1,4,7,10-tetraazacyclododecane-N,N',N",N"'-tetraacetic acid by capillary electrophoresis.
    Zhu X; Lever SZ
    Electrophoresis; 2002 May; 23(9):1348-56. PubMed ID: 12007137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Towards the rational design of MRI contrast agents: δ-substitution of lanthanide(III) NB-DOTA-tetraamide chelates influences but does not control coordination geometry.
    Carney CE; Tran AD; Wang J; Schabel MC; Sherry AD; Woods M
    Chemistry; 2011 Sep; 17(37):10372-8. PubMed ID: 21837722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Density-functional theory structures of 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid complexes for ions across the lanthanide series.
    Smentek L; Andes Hess B; Cross JP; Charles Manning H; Bornhop DJ
    J Chem Phys; 2005 Dec; 123(24):244302. PubMed ID: 16396532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thiol-reactive lanthanide chelates for phasing protein X-ray diffraction data.
    Purdy MD; Ge P; Chen J; Selvin PR; Wiener MC
    Acta Crystallogr D Biol Crystallogr; 2002 Jul; 58(Pt 7):1111-7. PubMed ID: 12077430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and luminescence properties of new red-shifted absorption lanthanide(III) chelates suitable for peptide and protein labelling.
    Maindron N; Poupart S; Hamon M; Langlois JB; Plé N; Jean L; Romieu A; Renard PY
    Org Biomol Chem; 2011 Apr; 9(7):2357-70. PubMed ID: 21321764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DOTA-M8: An extremely rigid, high-affinity lanthanide chelating tag for PCS NMR spectroscopy.
    Häussinger D; Huang JR; Grzesiek S
    J Am Chem Soc; 2009 Oct; 131(41):14761-7. PubMed ID: 19785413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of novel 1,4,7,10-tetraazacyclodecane-1,4,7,10-tetraacetic acid (DOTA) derivatives for chemoselective attachment to unprotected polyfunctionalized compounds.
    Knör S; Modlinger A; Poethko T; Schottelius M; Wester HJ; Kessler H
    Chemistry; 2007; 13(21):6082-90. PubMed ID: 17503419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-range-distance NMR effects in a protein labeled with a lanthanide-DOTA chelate.
    Vlasie MD; Comuzzi C; van den Nieuwendijk AM; Prudêncio M; Overhand M; Ubbink M
    Chemistry; 2007; 13(6):1715-23. PubMed ID: 17115462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of regioisomerism on the coordination chemistry and CEST properties of lanthanide(III) NB-DOTA-tetraamide chelates.
    Slack JR; Woods M
    J Biol Inorg Chem; 2014 Feb; 19(2):173-89. PubMed ID: 24287873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of functionalised HP-DO3A chelating agents for conjugation to biomolecules.
    Barge A; Cappelletti E; Cravotto G; Ferrigato A; Lattuada L; Marinoni F; Tei L
    Org Biomol Chem; 2009 Sep; 7(18):3810-6. PubMed ID: 19707687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.